Arrowstreet Capital, Limited Partnership Bioventus Inc. Transaction History

Arrowstreet Capital, Limited Partnership

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$6.82 - $13.82 $599,805 - $1.22 Million	-87,948 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$11.65 - $15.28 $2.95 Million - $3.87 Million	-253,561 Reduced 74.25%	87,948 $1.24 Million
Q4 2021 Feb 14, 2022	BUY	$12.37 - $16.77 $2.95 Million - $4 Million	238,568 Added 231.75%	341,509 $4.95 Million
Q3 2021 Nov 12, 2021	BUY	$13.7 - $17.25 $1.27 Million - $1.6 Million	92,741 Added 909.23%	102,941 $1.46 Million
Q2 2021 Aug 13, 2021	BUY	$13.75 - $18.8 $140,250 - $191,760	10,200 New	10,200 $180,000

141

45.8M

179K

124K

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $647M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.